Funding opportunities and news for global health researchers from the Fogarty International Center at the U.S. National Institutes of Health.

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Upcoming Implementation Research Funding Opportunity for Chronic Disease Prevention

  • Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Research for Chronic Disease Prevention Across the Lifespan (R01 Clinical Trial Optional) (NOT-TW-21-008)

NIH News

Important news from NIH for all grantees.

  • Reminder: FORMS-G Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2022 - New Grant Application Instructions Now Available(NOT-OD-22-018)
  • Reminder: Notice of NIHs Encouragement of Applications Supporting Individuals from Underrepresented Ethnic and Racial Groups as well as Individuals with Disabilities(NOT-OD-22-019)

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

NIH funding opportunities for which foreign organizations may apply.

  • Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) (PAR-22-049) Application Receipt Dates: Multiple dates, see announcement.
  • Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) (RFA-AI-21-075) Application Receipt Date: February 8, 2022
  • Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) (RFA-MH-22-105) Application Receipt Date: January 6, 2022
  • Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) (RFA-MH-22-106) Application Receipt Date: January 6, 2022
  • Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) (RFA-AG-23-001)
    Application Receipt Date: March 3, 2022
  • Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) (RFA-AG-23-002) Application Receipt Date: March 3, 2022
  • Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) (RFA-CA-21-046)
    Application Receipt Date: December 28, 2021
  • Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required) (RFA-HD-22-017)
    Application Receipt Date: March 30, 2022
  • Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) (RFA-HD-22-023) Application Receipt Date: March 30, 2022
  • Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) (RFA-HD-23-005) Application Receipt Date: March 30, 2022
  • Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-22-004)
    Application Receipt Date: January 18, 2022
  • Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) (RFA-RM-22-005)
    Application Receipt Date: January 19, 2022

NIH Notices of Special Interest (NOSIs) that may be of interest to global health researchers.

  • Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity (NOT-AI-21-072)
  • Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes (NOT-AI-21-080)
  • Notice of Special Interest (NOSI): NIDDK T32 Medical Student Research Training Administrative Supplement (NOT-DK-21-015)
  • Notice of Special Interest: Administrative Supplements for NIA-VA Mentored Physician-Scientist Award in Alzheimers Disease and Related Dementias (AD/ADRD) (NOT-AG-21-054)
  • Notice of Special Interest (NOSI): IDEA2Health: Innovative Data Evaluation and Analysis to Health (NOT-HL-22-001)

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

Featured Fogarty News and Information

NIH COVID-19 Funding and News

Other Funding News

NIH funding news that may be relevant to global health researchers.

  • Notice of NIEHS Participation on PAR-22-048 "Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)" (NOT-ES-22-002)
  • Notice to Rescind NOT-DC-21-006, "Notice of Invitation for Applicants to NIDCD PAR-21-063 and PAR-21-064 to Consult with the NCATS Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission" (NOT-DC-22-003)
  • Notice to Extend Expiration Date for PAR-19-145 "NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03)" (NOT-DE-21-017)
  • Notice of NHLBI Participation in RFA-NS-21-010: "HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)" (NOT-HL-21-039)
  • Notice of NHLBI Participation in RFA-NS-21-015: "HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development (U19 Clinical Trial Not Allowed)" (NOT-HL-21-040)
  • Notice of NHLBI Participation in RFA-NS-21-029: "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)" (NOT-HL-21-041)
  • Notice of Extension of PAR-19-189, "Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)" (NOT-MH-22-035)

Upcoming Deadlines


This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Fogarty International Center at NIH National Institutes of Health Bethesda, MD 20892 (301) 496-2075 [email protected] GovDelivery logo